Moffitt Cancer Center, Tampa, Florida, USA; University of South Florida, Tampa, Florida, USA.
Moffitt Cancer Center, Tampa, Florida, USA.
J Pain Symptom Manage. 2019 Aug;58(2):289-296.e2. doi: 10.1016/j.jpainsymman.2019.05.003. Epub 2019 May 20.
The Hospital Anxiety and Depression Scale (HADS) is a brief self-report measure commonly used to screen for symptoms of anxiety and depression in cancer patients. The HADS has demonstrated validity in over 100 languages, including Spanish. However, validation studies have largely used European Spanish-speaking samples with a variety of medical diagnoses.
The aim of this study was to examine the psychometric properties of the Spanish version of the HADS in a sample of Spanish-speaking Latina women with cancer in the U.S.
Participants (N = 242) completed self-report measures of anxiety and depression (HADS), quality of life (Functional Assessment of Cancer Therapy-General Version), cancer-related distress (Impact of Events Scale-Revised Version Intrusion Subscale), and cancer symptomatology (Memorial Symptom Assessment Scale-Short Form) before initiating chemotherapy and five to seven weeks later. Analyses evaluated internal consistency and test-retest reliability, construct validity, and convergent validity.
Factor analysis supported a two-factor structure as proposed by the original HADS developers (X [76, N = 242] = 143.3, P < 0.001, comparative fit index = 0.94, root-mean-square error of approximation = 0.06, and standardized root-mean-square residual = 0.06). The HADS and its subscales demonstrated good internal consistency (α = 0.83-0.88) and test-retest reliability (intraclass correlation coefficient = 0.76-0.82). Construct validity was evidenced by factor analysis and item-subscale, item-total, and subscale-total correlations. Convergent validity was demonstrated by strong positive correlations with cancer-related distress (r = 0.51-0.71) and symptom severity (r = 0.54-0.62) and strong negative correlations with quality of life (r = -0.63 to -0.76) (all P's < 0.001).
The Spanish version of the HADS evidenced sound psychometric properties in Latinas with cancer in the U.S., supporting its use in clinical oncology research and practice.
医院焦虑抑郁量表(HADS)是一种常用的简短自评量表,用于筛查癌症患者的焦虑和抑郁症状。HADS 已在 100 多种语言中得到验证,包括西班牙语。然而,验证研究主要使用的是具有多种医学诊断的欧洲西班牙语样本。
本研究旨在检验 HADS 西班牙语版本在西班牙裔美国癌症女性样本中的心理测量特性。
参与者(N=242)在开始化疗前和化疗后五到七周内完成了焦虑和抑郁自评量表(HADS)、癌症患者生活质量通用量表(功能评估癌症治疗-一般版本)、癌症相关困扰量表(修订版事件影响量表-侵入性子量表)和癌症症状评估量表(Memorial 症状评估量表-简短形式)。分析评估了内部一致性和重测信度、结构效度和会聚效度。
因子分析支持了 HADS 原开发者提出的两因素结构(X[76,N=242]=143.3,P<0.001,比较拟合指数=0.94,均方根误差近似值=0.06,标准化均方根残差=0.06)。HADS 及其分量表具有良好的内部一致性(α=0.83-0.88)和重测信度(组内相关系数=0.76-0.82)。结构效度通过因子分析、项目-分量表、项目-总分和分量表-总分相关性得到证实。会聚效度通过与癌症相关困扰(r=0.51-0.71)和症状严重程度(r=0.54-0.62)的强正相关以及与生活质量的强负相关(r=-0.63 至-0.76)(均 P<0.001)得到证明。
HADS 西班牙语版本在美国癌症拉丁裔人群中具有良好的心理测量特性,支持其在临床肿瘤学研究和实践中的应用。